BDBM590759 6-(4-fluorophenyl)-4-hydroxy- 1-(2-morpholinoethyl)-2-oxo- N-(spiro[3.3]heptan-2-yl)-1,2- dihydro-1,8-naphthyridine-3-carboxamide::US11564928, Compound 6

SMILES Oc1c(C(=O)NC2CC3(CCC3)C2)c(=O)n(CCN2CCOCC2)c2ncc(cc12)-c1ccc(F)cc1

InChI Key InChIKey=IFVYQCQMBSARGI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590759   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590759(US11564928, Compound 6 | 6-(4-fluorophenyl)-4-hydr...)
Affinity DataIC50: 6.10nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590759(US11564928, Compound 6 | 6-(4-fluorophenyl)-4-hydr...)
Affinity DataIC50: 1.00E+4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent